Browsing byAuthorPozzoli, M

Jump to a point in the index:
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2018-10-13Nanoemulsion-enabled oral delivery of novel anticancer ω-3 fatty acid derivativesPereira, GG; Rawling, T; Pozzoli, M; Pazderka, C; Chen, Y; Dunstan, CR; Murray, M; Sonvico, F
2017-09-02Development of a Soluplus budesonide freeze-dried powder for nasal drug deliveryPozzoli, M; Traini, D; Young, PM; Sukkar, MB; Sonvico, F
2016-12-07The nasal delivery of nanoencapsulated statins – An approach for brain deliveryClementino, A; Batger, M; Garrastazu, G; Pozzoli, M; Del Favero, E; Rondelli, V; Gutfilen, B; Barboza, T; Sukkar, MB; Souza, SAL; Cantù, L; Sonvico, F
2016-11-16Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition studyMartignoni, I; Trotta, V; Lee, WH; Loo, CY; Pozzoli, M; Young, PM; Scalia, S; Traini, D
2016-10-02Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulationPozzoli, M; Rogueda, P; Zhu, B; Smith, T; Young, PM; Traini, D; Sonvico, F
2016-10-01Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal productsPozzoli, M; Ong, HX; Morgan, L; Sukkar, M; Traini, D; Young, PM; Sonvico, F
2015-06-01CHARACTERIZATION OF A COMMERCIAL NASAL POWDER DRUG DELIVERY DEVICEPozzoli, M; Sonvico, F; Zhu, B; Rogueda, P; Traini, D; Young, P
2015-01-01Opportunities and challenges for the nasal administration of nanoemulsionsComfort, C; Garrastazu, G; Pozzoli, M; Sonvico, F
2014-01Optimization of RPMI 2650 Cells as a Model for Nasal MucosaPozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D